All News #Library
Quality
Fresenius Kabi Issues Voluntary Recall of Sodium Acetate Injection, USP
07 Mar 2022 //
BUSINESSWIRE
FDA Issues Form 483 to Fresenius Kabi USA LLC
29 Jan 2021 //
FDA
Recall report: Fresenius Kabi yanks inflammatory med Ketorolac after finding
11 Jan 2021 //
ENDPTS
Special 510(k)s: CDRH’s Proposed Program Expansion Draws Mixed Reactions
04 Dec 2018 //
RAPS

Market Place
Sourcing Support